EORTC Genito-Urinary Cancers Group

A prospective randomised phase III study of androgen deprivation therapy with or without local
radiotherapy with or without abiraterone acetate and prednisone in patient with metastatic
hormone-na´ve prostate cancer

Long term adjuvant hormonal treatment with LHRH analogue versus no further
treatment in locally advanced prostatic carcinoma treated by external irradiation
and a six months combined androgen blockade - A phase III study.
(Joint study of the EORTC Radiotherapy Cooperative Group and the EORTC Genito-Urinary Tract Cancer Cooperative Group)

Phase II Chemotherapy with 5-Aza-2'-deoxycytidine in Patients with Nonseminomatous Testicular or Extragonadal Germ Cell Tumors That Are Progressive, Measurable, and Metastatic (Summary Last Modified 05/88)

Phase III prospective randomized trial for the study of TUR + a single intravesical instillation of Epirubicin versus TUR alone in single, primary or recurrent, Ta/T1 papillary carcinoma of the bladder.

Phase III protocol for a randomized prospective study of the treatment of patients with metastatic prostatic cancer to compare the therapeutic effect of orchidectomy versus LHRH-analogue depot preparation supplemented by an antiandrogen